Postoperative Troponin in Children With Congenital Heart Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01616394
Recruitment Status :
First Posted : June 11, 2012
Last Update Posted : November 19, 2014
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Information provided by (Responsible Party):
Momeni, Cliniques universitaires Saint-Luc- Université Catholique de Louvain
The aim of the study is to evaluate the value of postoperative troponin in the prediction of mid term and long term mortality and morbidity in children with congenital heart disease undergoing cardiac surgery.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
up to 10 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
children with congenital heart disease admitted for surgery
all children with congenital heart disease between 0-10 years admitted for elective or emergency corrective or palliative cardiac surgery